| Income Statement |
| Operating Expenses | 119.41M |
|
| Research and Development Expense | 83.61M |
| Selling, General and Administrative Expense | 35.80M |
| Operating Income | -119.41M |
| Income Tax Expense | 168.00K |
| Net Income | -109.28M |
| Net Income Common Stock | -109.28M |
| Net Income Common Stock (USD) | -109.28M |
| Consolidated Income | -109.28M |
| Earnings per Basic Share | -1.39 |
| Earnings per Basic Share (USD) | -1.39 |
| Earnings per Diluted Share | -1.39 |
| Earning Before Interest & Taxes (EBIT) | -109.11M |
| Earning Before Interest & Taxes (USD) | -109.11M |
| Weighted Average Shares | 78.67M |
| Weighted Average Shares Diluted | 78.67M |
| Balance Sheet |
| Cash and Equivalents | 159.73M |
| Cash and Equivalents (USD) | 159.73M |
| Investments | 1.13B |
| Investments Current | 1.13B |
| Current Assets | 1.31B |
| Total Assets | 1.33B |
| Current Liabilities | 81.05M |
| Total Liabilities | 156.78M |
| Accumulated Retained Earnings (Deficit) | -1.08B |
| Accumulated Other Comprehensive Income | -1.35M |
| Shareholders Equity | 1.17B |
| Shareholders Equity (USD) | 1.17B |
| Assets Non-Current | 23.21M |
| Liabilities Non-Current | 75.73M |
| Trade and Non-Trade Payables | 22.14M |
| Cash Flow |
| Net Cash Flow from Financing | 9.80M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -102.01M |
| Issuance (Purchase) of Equity Shares | 10.14M |
| Net Cash Flow from Investing | -19.41M |
| Net Cash Flow - Investment Acquisitions and Disposals | -19.41M |
| Net Cash Flow from Operations | -92.40M |
| Share Based Compensation | 28.88M |